Shin Nippon Biomedical Laboratories, Ltd. Cash Flow Statement: Consolidated Financial Analysis & Historical Data (15 Years)

Cash Flow

Shin Nippon Biomedical Laboratories, Ltd. Cash flow Statement

Figures in Million

Consolidated Cash Flow Results

Mar'25

Mar'24

Mar'23

Mar'22

Mar'21

Mar'20

No of Months

Profit Before Tax

6,013.00

6,974.00

7,759.00

8,183.00

4,175.00

3,062.00

Adjustment

0.00

Changes In working Capital

1,079.00

-4,722.00

-2,894.00

601.00

1,075.00

-530.00

Cash Flow after changes in Working Capital

0.00

Cash Flow from Operating Activities

7,035.00

2,106.00

4,004.00

5,952.00

4,746.00

3,018.00

Cash Flow from Investing Activities

-11,612.00

-6,907.00

-5,930.00

-4,268.00

-268.00

-1,452.00

Cash Flow from Financing Activities

5,835.00

5,318.00

6,266.00

-4,911.00

-2,471.00

-1,452.00

Net Cash Inflow / Outflow

1,627.00

1,077.00

4,651.00

-2,731.00

2,036.00

108.00

Opening Cash & Cash Equivalents

0.00

Cash & Cash Equivalent on Amalgamation / Take over / Merger

0.00

Cash & Cash Equivalent of Subsidiaries under liquidations

0.00

Translation adjustment on reserves / op cash balances foreign subsidiaries

0.00

Effect of Foreign Exchange Fluctuations

369.00

559.00

311.00

496.00

29.00

-5.00

Closing Cash & Cash Equivalent

0.00

Figures in JPY Million
Seasonal companies are compared with the same quarter last year

Compare Cash Flow Results of Shin Nippon Biomedical Laboratories, Ltd.

Select Peers

Figures in Million

consolidated Cash Flow Results

Change(JPY)

Change(%)

Profit Before Tax

6013.099

10241

-4,228.00

-41.28%

Adjustment

0.00

0.00%

Changes In working Capital

1079.751

-2899

3,978.00

137.25%

Cash Flow after changes in Working Capital

0.00

0.00%

Cash Flow from Operating Activities

7035.243

6422

613.00

9.55%

Cash Flow from Investing Activities

-11612.146

-4005

-7,607.00

-189.94%

Cash Flow from Financing Activities

5835.072

-3008

8,843.00

293.99%

Net Cash Inflow / Outflow

1627.974

-616

2,243.00

364.28%

Opening Cash & Cash Equivalents

0.00

0.00%

Cash & Cash Equivalent on Amalgamation / Take over / Merger

0.00

0.00%

Cash & Cash Equivalent of Subsidiaries under liquidations

0.00

0.00%

Translation adjustment on reserves / op cash balances foreign subsidiaries

0.00

0.00%

Effect of Foreign Exchange Fluctuations

369.805

-25

394.00

1579.22%

Closing Cash & Cash Equivalent

0.00

0.00%

Cash Flow - Snapshot (Consolidated) - Mar'25

YoY Growth in year ended Mar 2025 is 233.94% vs -47.38% in Mar 2024

Mar'25

Mar'24

Change(%)

Cash Flow from Operating Activities

7,035.24

2,106.73

233.94%